Open Access
ARTICLE
Regorafenib Plus FOLFIRI With Irinotecan Dose Escalated According to Uridine Diphosphate Glucuronosyltransferase 1A1 Genotyping in Patients With Metastatic Colorectal Cancer
* Division of Gastroenterology and General Surgery, Department of Surgery, Kaohsiung Medical University Hospital,
Kaohsiung Medical University, Kaohsiung, Taiwan
† Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
‡ Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital,
Kaohsiung Medical University, Kaohsiung, Taiwan
§ Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
¶ Division of Trauma and Critical Care, Department of Surgery, Kaohsiung Medical University Hospital,
Kaohsiung Medical University, Kaohsiung, Taiwan
# Division of General Surgery Medicine, Department of Surgery, Kaohsiung Medical University Hospital,
Kaohsiung Medical University, Kaohsiung, Taiwan
** Department of Surgery, Faculty of Medicine, College of Medicine,
Kaohsiung Medical University, Kaohsiung, Taiwan
†† Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital,
Kaohsiung Medical University, Kaohsiung, Taiwan
‡‡ Department of Internal Medicine, Faculty of Medicine, College of Medicine,
Kaohsiung Medical University, Kaohsiung, Taiwan
§§ Department of Biomedical Science and Environmental Biology,
Kaohsiung Medical University, Kaohsiung, Taiwan
¶¶ Center for Biomarkers and Biotech Drugs, Kaohsiung Medical University, Kaohsiung, Taiwan